Duravit AG:企業の戦略・SWOT・財務分析

◆英語タイトル:Duravit AG - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY3920
◆発行会社(調査会社):MarketLine
◆発行日:2019年12月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:Construction and Real Estate
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Duravit AG – Strategy, SWOT and Corporate Finance Report
Summary

Duravit AG – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Duravit AG (Duravit) is a manufacturer and distributor of bathroom fixtures and accessories. The company offers a range of bathroom furniture, sanitary ceramics, accessories, whirl and well-being systems, shower trays and baths, and ceramic sinks. Its portfolio of products includes washbasins, vanity basins, faucets, furniture washbasins, toilets and bidets, bath and whirl tubs, urinals, showers and pools, shower toilets, steam showers and sauna, and bidet seats. The company markets its products through sales offices, and distributors in various countries. It has presence in several countries across Africa, Asia- Pacific, Europe, Latin America, the Middle East and North America. Duravit is headquartered in Hornberg, Germany.

Scope

- Detailed information on Duravit AG required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Duravit AG in the form of a SWOT analysis
- An in-depth view of the business model of Duravit AG including a breakdown and examination of key business segments
- Intelligence on Duravit AG’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Duravit AG, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Duravit AG and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Duravit AG as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Duravit AG’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Duravit AG: Company Overview
Duravit AG: Overview and Key Facts
Duravit AG: Overview
Duravit AG: Key Facts
Duravit AG: Key Employees
Duravit AG: Key Employee Biographies
Duravit AG: Major Products and Services
Duravit AG: Company History
Duravit AG: Locations and Subsidiaries
Duravit AG: Key Competitors
Duravit AG: Company Analysis
Duravit AG: Business Description
Duravit AG: SWOT Analysis
Duravit AG: SWOT Overview
Duravit AG: Strengths
Duravit AG: Weaknesses
Duravit AG: Opportunities
Duravit AG: Threats
Duravit AG: Recent Developments
Duravit AG: News and Events Summary
Duravit AG: Business Expansion
Duravit AG: Corporate Governance
Duravit AG: Research & Development
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Duravit AG: Key Facts
Table 2: Duravit AG: Key Employees
Table 3: Duravit AG: Company History
Table 4: Duravit AG: Locations and Subsidiaries
Table 5: Duravit AG: Key Competitors
Table 6: Duravit AG: News and Events Summary
Table 7: Duravit AG: Business Expansion
Table 8: Duravit AG: Corporate Governance
Table 9: Duravit AG: Research & Development

★海外企業調査レポート[Duravit AG:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Central Glass Co Ltd (4044):企業の財務・戦略的SWOT分析
    Central Glass Co Ltd (4044) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • CytImmune Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CytImmune Sciences Inc (CytImmune) is a clinical stage nanomedicine company that discovers, develops, and commercializes tumor-targeted therapies. The company develops nanotherapy platform, Aurimune, a tumor-targeted trojan horse. Its Aurimune binds TNF receptors on blood vessel cells at the …
  • Hanwha Solutions Corp (009830):企業の財務・戦略的SWOT分析
    Summary Hanwha Solutions Corp (Hanwha Solutions), a subsidiary of Hanwha Corp, is a provider of chemicals, solar energy solutions and advanced industrial materials. The company is engaged in the production of inorganic chemical, plastic and polymer products which include chlorine and caustic soda, p …
  • Idexx Laboratories Inc (IDXX):企業の財務・戦略的SWOT分析
    Idexx Laboratories Inc (IDXX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Pulmatrix Inc (PULM):企業の財務・戦略的SWOT分析
    Summary Pulmatrix Inc (Pulmatrix), formerly Ruthigen Inc is a clinical stage biopharmaceutical company that discovers and develops inhaled therapeutic products intended for prevention and treatment of respiratory diseases and infections. The company develops its pipeline products using its proprieta …
  • Empresas Copec SA (COPEC):企業の財務・戦略的SWOT分析
    Empresas Copec SA (COPEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • China National Offshore Oil Corporation:企業のM&A・事業提携・投資動向
    China National Offshore Oil Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China National Offshore Oil Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed re …
  • Wawa Inc:戦略・SWOT・企業財務分析
    Wawa Inc - Strategy, SWOT and Corporate Finance Report Summary Wawa Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Taiwan Semiconductor Manufacturing Company Limited:企業のM&A・事業提携・投資動向
    Taiwan Semiconductor Manufacturing Company Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Taiwan Semiconductor Manufacturing Company Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business de …
  • Frequency Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Frequency Therapeutics Inc (Frequency Therapeutics) is a biotechnology company that develops progenitor cell activation (PCA) therapies. The company’s small molecule drugs are used to activate progenitor cells for restoration of healthy tissue. Its lead program FX-322 is used to recreate sen …
  • Owens & Minor Inc (OMI):製薬・医療:M&Aディール及び事業提携情報
    Summary Owens & Minor Inc (Owens & Minor) is a healthcare services company, which provides supply chain services to healthcare providers and manufacturers of healthcare products. It provides logistics services for disposable medical supplies, devices and implants. Owens & Minor offers medical and su …
  • Natco Pharma Ltd (NATCOPHARM):企業の財務・戦略的SWOT分析
    Natco Pharma Ltd (NATCOPHARM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Tocagen Inc (TOCA):製薬・医療:M&Aディール及び事業提携情報
    Summary Tocagen Inc (Tocagen) is a clinical-stage cancer-selective gene therapy company that develops and commercializes product candidates for the treatment of cancer. The company offers lead product candidate such as Toca 511 and Toca FC, which is being investigated for the treatment of recurrent …
  • Xylem Inc (XYL):企業の財務・戦略的SWOT分析
    Xylem Inc (XYL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Alder Biopharmaceuticals Inc (ALDR):製薬・医療:M&Aディール及び事業提携情報
    Summary Alder Biopharmaceuticals Inc (Alder) is a biopharmaceutical company which develops, produces and markets monoclonal antibody therapeutics for the treatment of migraine, Cushing’s disease and autoimmune and inflammatory diseases. The company uses technologies such as the antibody selection sy …
  • Medigen Biotechnology Corp (3176)-医療機器分野:企業M&A・提携分析
    Summary Medigen Biotechnology Corp (MBC) is a pharmaceutical company that carries out the research and development of biopharmaceuticals for the treatment of liver diseases and cancers. It focuses at developing new therapeutics, principally in the area of cancer and liver diseases. The company’s pro …
  • The Wharf (Holdings) Limited:企業の戦略・SWOT・財務情報
    The Wharf (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary The Wharf (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • EBSCO Industries Inc:企業の戦略的SWOT分析
    EBSCO Industries Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • AMW GmbH:医療機器:M&Aディール及び事業提携情報
    Summary AMW GmbH (AMW) is a pharmaceutical company that develops and manufactures drug delivery systems for treatment in the areas of oncology, neurology, dermatology and pain. The company designs and develops novel transdermal drug delivery systems, microchip controlled patches and biodegradable su …
  • G1 Therapeutics Inc (GTHX)-製薬・医療分野:企業M&A・提携分析
    Summary G1 Therapeutics Inc (G1 Therapeutics), formerly G Zero Therapeutics Inc is a healthcare company that develops novel, and small molecule therapies. The company pipeline products include CDK4/6, trilaciclib G1T28 a drug candidate; G1T38 a potential best compound, and G1T48. It undertakes disco …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆